pazopanib

Generic: pazopanib

Labeler: golden state medical supply, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pazopanib
Generic Name pazopanib
Labeler golden state medical supply, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

pazopanib 200 mg/1

Manufacturer
Golden State Medical Supply, Inc.

Identifiers & Regulatory

Product NDC 51407-872
Product ID 51407-872_445b5e3e-5de0-323d-e063-6394a90a5fae
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217713
Listing Expiration 2026-12-31
Marketing Start 2023-10-19

Pharmacologic Class

Established (EPC)
kinase inhibitor [epc]
Mechanism of Action
protein kinase inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] cytochrome p450 2d6 inhibitors [moa] cytochrome p450 2c8 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51407872
Hyphenated Format 51407-872

Supplemental Identifiers

RxCUI
867502
UNII
7RN5DR86CK
NUI
N0000175605 N0000175076 N0000182141 N0000182137 N0000187062

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pazopanib (source: ndc)
Generic Name pazopanib (source: ndc)
Application Number ANDA217713 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/1
source: ndc
Packaging
  • 120 TABLET in 1 BOTTLE (51407-872-12)
source: ndc

Packages (1)

Ingredients (1)

pazopanib (200 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "445b5e3e-5de0-323d-e063-6394a90a5fae", "openfda": {"nui": ["N0000175605", "N0000175076", "N0000182141", "N0000182137", "N0000187062"], "unii": ["7RN5DR86CK"], "rxcui": ["867502"], "spl_set_id": ["115eb5bb-1403-fb3d-e063-6394a90ad320"], "pharm_class_epc": ["Kinase Inhibitor [EPC]"], "pharm_class_moa": ["Protein Kinase Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]"], "manufacturer_name": ["Golden State Medical Supply, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (51407-872-12)", "package_ndc": "51407-872-12", "marketing_start_date": "20240108"}], "brand_name": "Pazopanib", "product_id": "51407-872_445b5e3e-5de0-323d-e063-6394a90a5fae", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "51407-872", "generic_name": "Pazopanib", "labeler_name": "Golden State Medical Supply, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pazopanib", "active_ingredients": [{"name": "PAZOPANIB", "strength": "200 mg/1"}], "application_number": "ANDA217713", "marketing_category": "ANDA", "marketing_start_date": "20231019", "listing_expiration_date": "20261231"}